IDG was one of the accommodation rental platform's seed investors, and has come back to co-lead its latest round, which will go to growth and technology development.

Spun out of orphan drug accelerator Cydan Development, Imara will seek to develop a sickle cell disease treatment licensed from investor Lundbeck.

IDG Capital has participated in a funding round for technology company Tongdun, which uses big data to provide anti-theft and anti-fraud services.

The social shopping platform has now raised in excess of $70m altogether, having completed a second successive $25m round featuring Shea Ventures.

Unilever Ventures was among the investors as UK-based location-based adtech company Blis raised capital that will support an expansion into the US.

Boehringer Ingelheim returned to reinvest in the in-vitro diagnostics technology company, taking its overall funding to more than $50m as it gears up to release its product.

The vehicle financing provider has followed a BAIC-backed series A round last year with $33.5m of series A+ funding from China Growth Capital and Matrix Partners.

Henery Crown and Company joined the Brazil-based medical device and diagnostics equipment supplier for a series C round that boosted its total funding to $47m.

SoftBank has made its third investment in X.ai, which is developing an electronic personal assistant that can schedule meetings, bringing its overall funding to almost $35m.

UCB and Roche were among the investors in a Deerfield Management-led series B round that pushed the orphan disease treatment developer's total VC funding to $48m.